1Chedid MB, Chedid MF, Ilha DO,et al. Community-acquired pneumonia by Chlamydophila pneumoniae, a clinical and incidence study in Brazil[J]. Braz J Infect Dis , 2007, 11(1) : 75-82.
2Nakashima K, Tanaka T, Kramer MH, et al . Outbreak of Chlamydia pneumoniae infection in a Japanese nursing home, 1999-2000[J]. Infect Control Hosp Epidemiol , 2006, 27 (11) :1171-1177.
3Lee KJ. Outbreak of respiratory tract infections on an islet in Koreat possible Chlamydia pneumoniae infection[J]. Jpn J Infect Dis , 2006, 59(5) : 294-298.
4Lindan C,Mathur M, Kumta S,et al . Utility of pooled urine specimens for detection of Chlamydia traehomatis and Neisseria gonorrhoeae in men attending public sexually transmitted infection clinics in Mumbai, India, by PCR[J]. J Clin Microbiol ,2005,43(4):1674-1677.
5Liu KT, Yang KY, Lee YC, et al . Risk factor analysis of acute respiratory distress syndrome among hospitalized patients with Chlamydophila pnetimoniae pneumonia[J]. J Chin Med Assoc , 2007 ,70(8) : 318-323,
6Mahony JB, Coombes BK, Chernesky MA. Chlamydia and Chlamydophila. In: Murray PR, Baron EJ, Jorgensen JH, eds. Manual of Clinical Microbiology[M]. 8 th ed. ASM Press: Washington DC , 2003. 991-1004.
7Hohenthal U, Vainionp R, Meurman O, et al . Aetiological diagnosis of community acquired pneumonia:Utility of rapid microbiological methods with respect to disease severity[J]. Scand J Infect Dis ,2007 27:1-8.
8Rasmussen ZA, Bari A , Qazi S , et al. Randomized controlled trial of standard versus double dose cotrimoxazole for childhood pneumonia in Pakistan[J]. Bull World Health Organ , 2005 , 83(1) : 10-19.
9Hale KA , Isaacs D. Antibiotics in childhood pneumonia[J].Pediatric respiratory reviews , 2006 , 7(2) : 145-151.
10Skerk V, Krhen I, LisicM, et al . Comparative randomized pilot study of azithromycin and doxycycline efficacy in the treatment of prostate infection caused by Chlamydia trachomatis[J]. Int J Antimicrob Agents , 2004, 24 (2) : 188-191.
2Dowell SF,Peeling RW,Boman J, et al.Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada). Clin Infect Dis, 2001, 33 (4):492- 503.
3Hvidsten D, Halvorsen DS, Berdal BP, et al. Chlamydophila pneumoniae diagnostics:importance of methodology in relation to timing of sampling. Clin Microbiol Infect,2009,15(1):42-49.
4Mandell LA,Wunderink RG,Anzueto A,et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the managerment of community-acquired pneumonia in aduhs.Clin Infect Dis, 2007, 45(5):670-671.
5Oosterheert II,Van Loon AM,Achuurman R,et al. Impact of rapid detection of viral and atypical bacterial pathogens by real-time polymerase chain reaction for patients with lower respiratory tract infection.Clin Infect Dis, 2005, 41(10):1445-1447.
6Guillermo Madico, Thomas C.Quinn, Jens Boman,et al.Touchdown enzyme time releasa-PCR for detection and identification of chlamydia trachomatis,C.pneumoniae,and C.psittaci using the 16s and 16s-23s spacer rRNA genes.Journal of Clinical micribiology, 2000,38(3):1085-1093.
7Tong CY,Sillis M. Detection of Chlamydia pneumoniae and Chlamydia psittac in sputum samples by PCR.I Clin Pathol, 1993,46(4):313-317.
8Harris JA, Kolokathis A, Campbell M, et al. Safety and efficacy of azithromycin in the treatment of community-acquired pneumonia in chiildren.Pediatr Infect Dis J,1998,17(10):865-871.
9Hammerschlag MR,Roblin PM. Microbiologic efficacy of moxi- floxacin for the treatment of aommunity-acquired pneumonia due to Chlaydia pneumoniae.lnt J Antimierob Agents, 2000,5(2):149- 152.
10Thomas M, File, Jr.,et al.The science of selecting antimicrobials for community-acquired pneumonia (CAP). J Manag Care Pharm, 2009,15(2):S5-S 11.
